Details of HTA journal title
Last updated: 31 August 2010 - Next update due: 7 September 2010
Research type: |
NICE Technology Assessment Report (TAR) |
Title (lead author) etc: |
Cyclooxygenase-2 selective non-steroidal anti-inflammatory (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis or rheumatoid arthritis: a systematic review and economic evaluation (Chen) 178 pages, Volume 12, number 11 |
Link to NICE guidance page |
|
DOI |
10.3310/hta12110 |
View/print executive summary
View/print abstract
View full text in pdf format (1172 KB) View separate 124 page appendix in pdf format (507 KB)
The appendix is only available electronically. It is not available in the printed version.  This title is available on our CD-ROM of the journal. Order a CD-ROM - free of charge worldwide.
Go to our correspondence page to comment on this publication
|
|
This report should be referenced as follows: |
Chen Y-F, Jobanputra P, Barton P, Bryan S, Fry-Smith A, Harris G, et al. Cyclooxygenase-2 selective non-steroidal anti-inflammatory (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis or rheumatoid arthritis: a systematic review and economic evaluation. Health Technol Assess 2008;12(11). |
Project ref: |
03/34/01 |
Original project title: |
Clinical effectiveness and cost-effectiveness of cyclooxygenase-2 (COX-2) selective inhibitors (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis or rheumatoid arthritis. |
Chief Investigator: |
West Midlands Health Technology Assessment Collaboration (WMHTAC), University of Birmingham |
Start Date: |
November 2001 |
Date of publication in HTA journal series |
April 2008 |
Cost: |
This project was commissioned by the HTA programme on behalf of the National Institute for Health and Clinical Excellence on a call-off contract basis |
MeSH* index primary terms: |
OSTEOARTHRITIS Q-drug-therapy; ARTHRITIS-RHEUMATOID Q-drug-therapy; CYCLOOXYGENASE-INHIBITORS Q-therapeutic-use; ANTI-INFLAMMATORY-AGENTS-NON-STEROIDAL Q-therapeutic-use (* = Medical Subject Headings) |
MeSH* index secondary terms: |
HUMAN (* = Medical Subject Headings) |
NRR* number, if applicable: |
N0484131807 (*National Research Register) The National Research Register was a public database of ongoing and recently completed research projects funded by, or of interest to, the United Kingdom's National Health Service (NHS). It is now an archive of projects from early 2000 to September 2007. Search the NRR archive. |
Project Protocol: |
Project protocol not available |
Printed copies of this title despatched: |
99 (Figures relate to the previous calendar month) |
Downloads/Views of electronic version from website: |
115202 (Figures are cumulative.) Last updated 27th July 2010. |
URL of this page: |
http://www.hta.ac.uk/1383 |
News feeds